Qiao; Lixin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Qiao; Lixin.The latest application filed is for "compounds that enhance atoh1 expression".
Company Profile
8.51.54
- Qiao; Lixin - Andover MA
- Qiao; Lixin - Tewksbury MA
- Qiao; Lixin - Arlington VA
- Qiao; Lixin - Washington DC
Patent Activity
| Patent | Date |
|---|---|
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 11,351,168 - Singh , et al. June 7, 2 | 2022-06-07 |
| Compounds that enhance Atoh1 expression Grant 11,160,808 - Edge , et al. November 2, 2 | 2021-11-02 |
| MK2 inhibitors and uses thereof Grant 11,098,061 - Alexander , et al. August 24, 2 | 2021-08-24 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 10,828,300 - Singh , et al. November 10, 2 | 2020-11-10 |
| Compounds that Enhance Atoh1 Expression App 20200179394 - Edge; Albert ; et al. | 2020-06-11 |
| Protein kinase conjugates and inhibitors Grant 10,662,195 - Singh , et al. | 2020-05-26 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,596,172 - Singh , et al. | 2020-03-24 |
| Compounds that enhance Atoh1 expression Grant 10,406,163 - Edge , et al. Sept | 2019-09-10 |
| Heteroaryl Compounds And Uses Thereof App 20190192512 - Singh; Juswinder ; et al. | 2019-06-27 |
| Mk2 Inhibitors And Uses Thereof App 20190135835 - Alexander; Matthew David ; et al. | 2019-05-09 |
| Heteroaryl Compounds And Uses Thereof App 20190117650 - Singh; Juswinder ; et al. | 2019-04-25 |
| MK2 inhibitors and uses thereof Grant 10,138,256 - Alexander , et al. Nov | 2018-11-27 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,010,548 - Singh , et al. July 3, 2 | 2018-07-03 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,987,276 - Singh , et al. June 5, 2 | 2018-06-05 |
| ERK inhibitors and uses thereof Grant 9,980,964 - Haq , et al. May 29, 2 | 2018-05-29 |
| ERK inhibitors and uses thereof Grant 9,796,700 - Haq , et al. October 24, 2 | 2017-10-24 |
| Ligand-Directed Covalent Modification of Protein App 20170218353 - Petter; Russell C. ; et al. | 2017-08-03 |
| Erk Inhibitors And Uses Thereof App 20170210729 - Haq; Nadia ; et al. | 2017-07-27 |
| HCV protease inhibitors and uses thereof Grant 9,694,086 - Petter , et al. July 4, 2 | 2017-07-04 |
| Protein Kinase Conjugates and Inhibitors App 20170174691 - Singh; Juswinder ; et al. | 2017-06-22 |
| HCV protease inhibitors and uses thereof Grant 9,676,785 - Niu , et al. June 13, 2 | 2017-06-13 |
| Hcv Protease Inhibitors And Uses Thereof App 20170137463 - Niu; Deqiang ; et al. | 2017-05-18 |
| Erk Inhibitors And Uses Thereof App 20170137406 - Haq; Nadia ; et al. | 2017-05-18 |
| Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ; et al. | 2017-04-13 |
| Compounds That Enhance ATOH1 Expression App 20170095481 - Edge; Albert ; et al. | 2017-04-06 |
| ERK inhibitors and uses thereof Grant 9,561,228 - Haq , et al. February 7, 2 | 2017-02-07 |
| Protein kinase conjugates and inhibitors Grant 9,556,426 - Singh , et al. January 31, 2 | 2017-01-31 |
| ERK inhibitors and uses thereof Grant 9,504,686 - Haq , et al. November 29, 2 | 2016-11-29 |
| Hcv Protease Inhibitors And Uses Thereof App 20160326216 - Niu; Deqiang ; et al. | 2016-11-10 |
| Heteroaryl Compounds And Uses Thereof App 20160303121 - Singh; Juswinder ; et al. | 2016-10-20 |
| Compounds that enhance Atoh1 expression Grant 9,433,610 - Edge , et al. September 6, 2 | 2016-09-06 |
| Hcv Protease Inhibitors And Uses Thereof App 20160243249 - Petter; Russell C. ; et al. | 2016-08-25 |
| HCV protease inhibitors and uses thereof Grant 9,422,333 - Niu , et al. August 23, 2 | 2016-08-23 |
| Hcv Protease Inhibitors And Uses Thereof App 20160235805 - Petter; Russell C. ; et al. | 2016-08-18 |
| 2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2 | 2016-08-09 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2 | 2016-03-29 |
| Erk Inhibitors And Uses Thereof App 20160082008 - Haq; Nadia ; et al. | 2016-03-24 |
| Erk Inhibitors And Uses Thereof App 20160002176 - Haq; Nadia ; et al. | 2016-01-07 |
| Mk2 Inhibitors And Uses Thereof App 20150376208 - ALEXANDER; Matthew David ; et al. | 2015-12-31 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2 | 2015-12-15 |
| HCV protease inhibitors and uses thereof Grant 9,163,061 - Petter , et al. October 20, 2 | 2015-10-20 |
| ERK inhibitors and uses thereof Grant 9,145,387 - Haq , et al. September 29, 2 | 2015-09-29 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ; et al. | 2015-08-06 |
| Hcv Protease Inhibitors And Uses Thereof App 20150175657 - Niu; Deqiang ; et al. | 2015-06-25 |
| Compounds that Enhance Atoh1 Expression App 20150157607 - Edge; Albert ; et al. | 2015-06-11 |
| HCV protease inhibitors and uses thereof Grant 8,980,935 - Niu , et al. March 17, 2 | 2015-03-17 |
| Hcv Protease Inhibitors And Uses Thereof App 20150031106 - Niu; Deqiang ; et al. | 2015-01-29 |
| Inhibiting Eph B-3 kinase Grant 8,927,545 - Qiao , et al. January 6, 2 | 2015-01-06 |
| Hcv Protease Inhibitors And Uses Thereof App 20140323465 - Niu; Deqiang ; et al. | 2014-10-30 |
| Compounds that enhance Atoh1 expression Grant 8,859,597 - Edge , et al. October 14, 2 | 2014-10-14 |
| Erk Inhibitors And Uses Thereof App 20140228322 - Haq; Nadia ; et al. | 2014-08-14 |
| Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ; et al. | 2014-07-31 |
| HCV protease inhibitors and uses thereof Grant 8,778,877 - Niu , et al. July 15, 2 | 2014-07-15 |
| HCV protease inhibitors and uses thereof Grant 8,741,837 - Niu , et al. June 3, 2 | 2014-06-03 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2 | 2014-04-29 |
| Hcv Protease Inhibitors And Uses Thereof App 20130338062 - Niu; Deqiang ; et al. | 2013-12-19 |
| 2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2 | 2013-12-17 |
| HCV protease inhibitors and uses thereof Grant 8,524,760 - Niu , et al. September 3, 2 | 2013-09-03 |
| Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ; et al. | 2013-06-27 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2 | 2013-05-28 |
| Hcv Protease Inhibitors And Uses Thereof App 20130131105 - Petter; Russell C. ; et al. | 2013-05-23 |
| Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ; et al. | 2013-03-21 |
| Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ; et al. | 2013-03-14 |
| Heteroaryl Compounds And Uses Thereof App 20130065879 - Singh; Juswinder ; et al. | 2013-03-14 |
| Hcv Protease Inhibitors And Uses Thereof App 20130017991 - Niu; Deqiang ; et al. | 2013-01-17 |
| Bifunctional synthetic molecules Grant 8,354,116 - Carter , et al. January 15, 2 | 2013-01-15 |
| Compounds That Enhance Atoh1 Expression App 20120328580 - Edge; Albert ; et al. | 2012-12-27 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2 | 2012-12-25 |
| HCV protease inhibitors and uses thereof Grant 8,309,685 - Petter , et al. November 13, 2 | 2012-11-13 |
| HCV protease inhibitors and uses thereof Grant 8,293,705 - Niu , et al. October 23, 2 | 2012-10-23 |
| Pi3 Kinase Inhibitors And Uses Thereof App 20120258967 - Qiao; Lixin ; et al. | 2012-10-11 |
| Inhibiting EPH B-3 Kinase App 20120238597 - Qiao; Lixin ; et al. | 2012-09-20 |
| Hcv Protease Inhibitors And Uses Thereof App 20120190614 - Niu; Deqiang ; et al. | 2012-07-26 |
| Compounds that enhance Atoh1 expression Grant 8,188,131 - Edge , et al. May 29, 2 | 2012-05-29 |
| HCV protease inhibitors and uses thereof Grant 8,188,137 - Niu , et al. May 29, 2 | 2012-05-29 |
| Ligand-directed Covalent Modification Of Protein App 20110269244 - Petter; Russell C. ; et al. | 2011-11-03 |
| Pi3 Kinase Inhibitors And Uses Thereof App 20110230476 - NIU; DEQIANG ; et al. | 2011-09-22 |
| Protein Kinase Conjugates and Inhibitors App 20110117073 - Singh; Juswinder ; et al. | 2011-05-19 |
| Heteroaryl Compounds And Uses Thereof App 20100249092 - Singh; Juswinder ; et al. | 2010-09-30 |
| Hcv Protease Inhibitors And Uses Thereof App 20100069294 - Petter; Russell C. ; et al. | 2010-03-18 |
| Hcv Protease Inhibitors And Uses Thereof App 20100041674 - Niu; Deqiang ; et al. | 2010-02-18 |
| Hcv Protease Inhibitors And Uses Thereof App 20100041591 - Niu; Deqiang ; et al. | 2010-02-18 |
| Heteroaryl Compounds and Uses Thereof App 20100029610 - Singh; Juswinder ; et al. | 2010-02-04 |
| Hcv Protease Inhibitors And Uses Thereof App 20090306085 - Petter; Russell C. ; et al. | 2009-12-10 |
| Compounds That Enhance Atoh1 Expression App 20090232780 - Edge; Albert ; et al. | 2009-09-17 |
| Hcv Protease Inhibitors And Uses Thereof App 20090176858 - Niu; Deqiang ; et al. | 2009-07-09 |
| Bifunctional synthetic molecules App 20080312296 - Carter; Stephen G. ; et al. | 2008-12-18 |
| Inhibitors Of Phosphatidyl Myo-inositol Cycle App 20070213398 - Kozikowski; Alan P. ; et al. | 2007-09-13 |
| Inhibitors of phosphatidyl myo-inositol cycle Grant 7,153,843 - Kozikowski , et al. December 26, 2 | 2006-12-26 |
| Inhibitors of phosphatidyl myo-inositol cycle App 20040192770 - Kozikowski, Alan P. ; et al. | 2004-09-30 |
| Inhibitors of phosphatidyl myo-inositol cycle Grant 6,667,340 - Kozikowski , et al. December 23, 2 | 2003-12-23 |
| Phosphinylmethyl and phosphorylmethyl succinic and glutaric acid analogs as beta-secretase inhibitors App 20030078240 - Etcheberrigaray, Rene ; et al. | 2003-04-24 |
| Treatment of conditions associated with amyloid processing using PKC activators App 20030050302 - Etcheberrigaray, Rene ; et al. | 2003-03-13 |
| Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors App 20020187928 - Qiao, Lixin ; et al. | 2002-12-12 |
| Substituted 2-pyrrolidinone activators of PKC Grant 5,962,504 - Kozikowski , et al. October 5, 1 | 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 